Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 59

Sort by

Sort Order Select

Journal Articles

Development and Validation of a Cancer-Associated Venous Thromboembolism Clinical Risk Prediction (CAT-CR) Model in Newly Diagnosed Cancer Patients Treated with Cheomotherapy

Piyanuch Kongtim, MD, Kotchanut Litlueangdet, Darunee Emrat, MD BSc, Dhosaporn Charoenjit, MD, Supawee Saengboon, MD, Wasithep Limvorapitak, MD, Nonglak Kanitsap, MD, Hataiwan Ratanabunjerdkul, MD

Blood (2019) 134 (Supplement_1): 2421.

https://doi.org/10.1182/blood-2019-123682

Published: 2019

Journal Articles

KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) — Pharmacodynamics and Updated Results

Madan Jagasia, MD MS, Amandeep Salhotra, MD, Carlos R. Bachier, MD, James Essell, MD, Daniel J. Weisdorf, MD, Behyar Zoghi, MD PhD, Laurie S. Green, MD, Olivier Schueller, PhD, Alexandra Zanin-Zhorov, PhD, Jonathan M. Weiss, PhD, David Eiznhamer, PhD, Sanjay K. Aggarwal, Bruce R. Blazar, MD, Stephanie J. Lee, MD MPH

Blood (2018) 132 (Supplement 1): 602.

https://doi.org/10.1182/blood-2018-99-111896

Published: 2018

Journal Articles

Prognostic Impact of Gastrointestinal Involvement in Newly Diagnosed Diffuse Large B-Cell Lymphoma

David Kasouha, Nicola Lehners, Katharina Kriegsmann, MD MBA, Gerlinde Egerer, Anthony D Ho, Mathias Witzens-Harig, MD

Blood (2018) 132 (Supplement 1): 5400.

https://doi.org/10.1182/blood-2018-99-117125

Published: 2018

Journal Articles

Incidence and Risk Factors for Second Malignancies after Transplant in Long Term Survivors of Allogeneic Haematopoietic Stem Cell Transplant: A Single Centre Experience

Mohammed Snober, Richard Syzdlo, PhD, Jane Apperley, MB ChB MD, Aristeidis Chaidos, MD PhD, Edward Kanfer, PhD, Dragana Milojkovic, MBBS, PhD, Eduardo Olavarria, MD PhD, Renuka Palanicawandar, MD MRCP, FRCPath, Jiri Pavlu, MD MRCP, FRCPath, Jeannie F Todd, PhD, Nina Salooja, MD

Blood (2018) 132 (Supplement 1): 3417.

https://doi.org/10.1182/blood-2018-99-114229

Published: 2018

Journal Articles

Single Institution Experience of Gastrointestinal Involvement of Diffuse Large B- Cell Lymphoma: Presentation, Outcomes and Patterns of Treatment Failure

Puja C. Arora, MD, Victor M. Orellana-Noia, MD, Abeer Alfaraj, MBBS, Wenzinger Christopher, MD, Sandra Monson, PhD, Gina Petroni, PhD, Craig A. Portell, MD, Michael E. Williams, MD

Blood (2018) 132 (Supplement 1): 2982.

https://doi.org/10.1182/blood-2018-99-117651

Published: 2018

Journal Articles

Intravascular Hemolysis Leads to Increased Esophagus Smooth Muscle Contractions in Mice: Implication for Dysphagia and Odynophagia

Fabio H Silva, PhD, Eduardo C Alexandre, PhD, Fabiano B Calmasini, PhD, Carla Fernanda Franco-Penteado, BSc, PhD, Edson Antunes, PhD, Kleber Yotsumoto Fertrin, MD PhD, Fernando Ferreira Costa, MD PhD

Blood (2017) 130 (Supplement 1): 3470.

https://doi.org/10.1182/blood.V130.Suppl_1.3470.3470

Published: 2017

Journal Articles

Myeloid Malignancies Following Luminal Gastrointestinal Cancer: High Incidence of Deletion 5q and DNTM3A Mutations

Zachary D. Epstein-Peterson, MD, Sean M. Devlin, PhD, Eytan M. Stein, MD, Virginia M. Klimek, MD, Leonard B. Saltz, MD, Martin S. Tallman, MD

Blood (2017) 130 (Supplement 1): 1309.

https://doi.org/10.1182/blood.V130.Suppl_1.1309.1309

Published: 2017

Journal Articles

Fecal Microbiota Transplantation As Safe and Successful Therapy for Intestinal Graft-Versus-Host Disease

Yannouck F van Lier, MD, Pieter F de Groot, MD, Erfan Nur, MD PhD, Sacha S Zeerleder, MD PhD, Max Nieuwdorp, MD PhD, Bianca Blom, PhD, Mette D Hazenberg, MD PhD

Blood (2017) 130 (Supplement 1): 1986.

https://doi.org/10.1182/blood.V130.Suppl_1.1986.1986

Published: 2017

Journal Articles

Evaluation of Nudt15 -Guided Thiopurine Dose Individualization In Vivo Using CRISPR/Cas9-Edited Mouse Model

Takaya Moriyama, MDPhD, Rina Nishii, Laura Janke, DVM, PhD, Lie Li, Chen Ru, Scott A Brown, PhD, Ting-Nien Lin, Chase Suiter, Kentaro Kihira, MD, Hidemi Toyoda, MD PhD, Motohiro Kato, MD PhD, Atushi Manabe, MD PhD, Katsuyoshi Koh, MD, Masatoshi Takagi, MD PhD, Hiroki Hori, MD PhD, Jun J. Yang, PhD

Blood (2017) 130 (Supplement 1): 3879.

https://doi.org/10.1182/blood.V130.Suppl_1.3879.3879

Published: 2017

Journal Articles

Effectiveness and Safety of Rivaroxaban in Patients with Cancer-Associated Venous Thromboembolism

Christine G. Kohn, BS, PharmD, Gary H. Lyman, MD MPH, FRCP, Jan Beyer-Westendorf, MD, Alex C. Spyropoulos, MD, Thomas J. Bunz, PharmD, PhD, Craig I. Coleman, PharmD

Blood (2017) 130 (Supplement 1): 3717.

https://doi.org/10.1182/blood.V130.Suppl_1.3717.3717

Published: 2017

Journal Articles

Secondary Solid Cancers after Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience of 1374 Patients Including 812 Cord Blood Transplant Recipients

Yuki Asano-Mori, MD PhD, Mitsuhiro Yuasa, MD, Kosei Kageyama, MD, Daisuke Kaji, MD, Aya Nishida, MD, Shinsuke Takagi, Hisashi Yamamoto, MD, Go Yamamoto, MD PhD, Atsushi Wake, MD PhD, Akiko Yoneyama, MD PhD, Shigeyoshi Makino, MD PhD, Naoyuki Uchida, MD PhD, Shuichi Taniguchi, MD PhD

Blood (2017) 130 (Supplement 1): 4518.

https://doi.org/10.1182/blood.V130.Suppl_1.4518.4518

Published: 2017

Journal Articles

A Homozygous Germ Line Nonsense Mutation in BRCA1 Leading Fanconi Anemia and Neuroblastoma

Demirel Mehmet, Sule Unal, Fatma Gumruk, Nurten Ayse Akarsu

Blood (2016) 128 (22): 5073.

https://doi.org/10.1182/blood.V128.22.5073.5073

Published: 2016

Journal Articles

Safety and Clinical Activity of Temsirolimus in Combination with Rituximab and DHAP in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Report of the Prospective, Multicenter Phase II STORM Trial

Mathias Witzens-Harig, MD, Andreas Viardot, Ulrich Keller, Christian Buske, Anne Crombé, Elisabeth Hoenig, Johannes Atta, Johann Schmier, MD, Julia Meissner, MD, Anthony D. Ho, MD, Paul LaRosee, MD, Reinhard Marks, MD, Martin Dreyling, MD PhD, Georg Hess, MD

Blood (2016) 128 (22): 3028.

https://doi.org/10.1182/blood.V128.22.3028.3028

Published: 2016

Journal Articles

Secondary Cancer after Allogeneic Hematopoietic Stem Cell Transplantation

Yosuke Tanaka, MD, Saiko Kurosawa, MD, Kinuko Tajima, Yoshihiro Inamoto, MD PhD, Reiko Ito, MD, Takashi Tanaka, MD, Yoshitaka Inoue, MD, Takayuki Ozawa, MD, Akihisa Kawajiri, MD, Akio Onishi, MD, Keiji Okinaka, MD, Shigeo Fuji, MD, Sung-Won Kim, MD, Ryuji Tanosaki, MD PhD, Takuya Yamashita, MD PhD, Takahiro Fukuda, MD

Blood (2015) 126 (23): 3162.

https://doi.org/10.1182/blood.V126.23.3162.3162

Published: 2015

Journal Articles

Transformed Phenotype of Bone Marrow Stromal Cell Lines Derived from K14E7 Fancd2 -/- mice

Aranee Sivanathan, Xichen Zhang, Darcy Franicola, Shaonan Cao, Donna Shields, Michael W Epperly, PhD, Joel S. Greenberger, MD

Blood (2015) 126 (23): 4795.

https://doi.org/10.1182/blood.V126.23.4795.4795

Published: 2015

Journal Articles

A Phase I Trial of Total Marrow and Lymphoid Irradiation (TMLI)-Based Transplant Conditioning in Patients (Pts) with Relapsed/Refractory Acute Leukemia

Anthony Selwyn Stein, MD, Jeffrey Y. C. Wong, MD, Joycelynne Palmer, PhD, Margaret O'Donnell, MD, David S. Snyder, MD, Ni-Chun Tsai, Biostatition, Pablo Miguel Parker, MD, Ricardo Spielberger, MD, Len Farol, MD, Guido Marcucci, MD, Eric Radany, MD, Tim Schultheiss, MD, An Liu, MD, Ibrahim Aldoss, MD, Stephen J. Forman, MD

Blood (2015) 126 (23): 735.

https://doi.org/10.1182/blood.V126.23.735.735

Published: 2015

Journal Articles

Dominant NFKB1 Mutations Cause Antibody Deficiency and Autoinflammatory Episodes

Blood (2015) 126 (23): 206.

https://doi.org/10.1182/blood.V126.23.206.206

Published: 2015

Journal Articles

National Epidemiology of Venous Thromboembolism in Patients with Malignancy in United States from 1993 to 2012

Kathan Dilipbhai Mehta, MBBS, MPH, Leonard Appleman, MDPhD, Hong Wang, PhD, Roy E. Smith, MD, Rahul Atul Parikh, MD PhD

Blood (2015) 126 (23): 2060.

https://doi.org/10.1182/blood.V126.23.2060.2060

Published: 2015

Journal Articles

Safety and Clinical Activity of Temsirolimus in Combination with Rituximab and DHAP in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Results of the Part I Cohort of the STORM Trial

Mathias Witzens-Harig, MD, Ulrich Keller, Andreas Viardot, MD, Christian Buske, MD, Anne Crombé, Elisabeth Hoenig, Julia Meissner, MD, Anthony D Ho, MD, Reinhard Marks, Martin H. Dreyling, MD PhD, Georg Hess, MD

Blood (2015) 126 (23): 2727.

https://doi.org/10.1182/blood.V126.23.2727.2727

Published: 2015

Journal Articles

Emerging Risks of AML/MDS and Other Myeloid Neoplasms Following Chemotherapy for First Primary Malignancy, 2000-2012

Lindsay M Morton, PhD, Graca M. Dores, MD MPH, Meredith S Shiels, PhD, Martha S Linet, MD MPH, Jop C Teepen, Clara J.K. Lam, PhD, Margaret A. Tucker, MD, Rochelle E Curtis, MA

Blood (2015) 126 (23): 562.

https://doi.org/10.1182/blood.V126.23.562.562

Published: 2015

NARROW

Development and Validation of a Cancer-Associated Venous Thromboembolism Clinical Risk Prediction (CAT-CR) Model in Newly Diagnosed Cancer Patients Treated with Cheomotherapy

KD025-208: A Phase 2a Study of KD025 for Patients with Chronic Graft Versus Host Disease (cGVHD) — Pharmacodynamics and Updated Results

Prognostic Impact of Gastrointestinal Involvement in Newly Diagnosed Diffuse Large B-Cell Lymphoma

Incidence and Risk Factors for Second Malignancies after Transplant in Long Term Survivors of Allogeneic Haematopoietic Stem Cell Transplant: A Single Centre Experience

Single Institution Experience of Gastrointestinal Involvement of Diffuse Large B- Cell Lymphoma: Presentation, Outcomes and Patterns of Treatment Failure

Intravascular Hemolysis Leads to Increased Esophagus Smooth Muscle Contractions in Mice: Implication for Dysphagia and Odynophagia

Myeloid Malignancies Following Luminal Gastrointestinal Cancer: High Incidence of Deletion 5q and DNTM3A Mutations

Fecal Microbiota Transplantation As Safe and Successful Therapy for Intestinal Graft-Versus-Host Disease

Evaluation of Nudt15 -Guided Thiopurine Dose Individualization In Vivo Using CRISPR/Cas9-Edited Mouse Model

Effectiveness and Safety of Rivaroxaban in Patients with Cancer-Associated Venous Thromboembolism

Secondary Solid Cancers after Allogeneic Hematopoietic Stem Cell Transplantation: A Single Center Experience of 1374 Patients Including 812 Cord Blood Transplant Recipients

A Homozygous Germ Line Nonsense Mutation in BRCA1 Leading Fanconi Anemia and Neuroblastoma

Safety and Clinical Activity of Temsirolimus in Combination with Rituximab and DHAP in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Report of the Prospective, Multicenter Phase II STORM Trial

Secondary Cancer after Allogeneic Hematopoietic Stem Cell Transplantation

Transformed Phenotype of Bone Marrow Stromal Cell Lines Derived from K14E7 Fancd2 -/- mice

A Phase I Trial of Total Marrow and Lymphoid Irradiation (TMLI)-Based Transplant Conditioning in Patients (Pts) with Relapsed/Refractory Acute Leukemia

Dominant NFKB1 Mutations Cause Antibody Deficiency and Autoinflammatory Episodes

National Epidemiology of Venous Thromboembolism in Patients with Malignancy in United States from 1993 to 2012

Safety and Clinical Activity of Temsirolimus in Combination with Rituximab and DHAP in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Results of the Part I Cohort of the STORM Trial

Emerging Risks of AML/MDS and Other Myeloid Neoplasms Following Chemotherapy for First Primary Malignancy, 2000-2012

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only